Edition:
United States

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
23 Feb 2018
Change (% chg)

$-0.02 (-2.08%)
Prev Close
$1.01
Open
$1.03
Day's High
$1.03
Day's Low
$0.98
Volume
31,861
Avg. Vol
71,052
52-wk High
$1.34
52-wk Low
$0.80

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 4 21.05 82.70 0.00 2.93
Earnings (per share)
Quarter Ending Mar-18 1 -0.07 -0.07 -0.07 --
Quarter Ending Jun-18 1 -0.07 -0.07 -0.07 --
Year Ending Dec-18 4 -0.11 0.29 -0.27 0.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. -- 285.81 46.17
P/E Low - Last 5 Yrs. -- 93.64 24.19
Beta -- 0.81 0.81
Price to Sales (TTM) -- 137.83 8.35
Price to Book (MRQ) -- 20.52 5.22
Price to Tangible Book (MRQ) -- 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions -- 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 58.16 7.57
Sales - 5 Yr. Growth Rate -- 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate -- 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) -- 6.12 3.39
LT Debt to Equity (MRQ) -- 16.21 12.39
Total Debt to Equity (MRQ) -- 18.27 15.84
Interest Coverage (TTM) -- -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -230.69 14.70
Operating Margin (TTM) -- -487.70 4.10
Operating Margin - 5 Yr. Avg. -- -247.29 9.99
Pre-Tax Margin (TTM) -- -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -- -253.91 10.24
Net Profit Margin (TTM) -- -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -- -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,863,557 817,554,851
Net Income/Employee (TTM) -- -520,338 95,586,843
Receivable Turnover (TTM) -- 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) -- 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.04 10.73
Return on Assets - 5 Yr. Avg. -- -0.14 12.03
Return on Investment (TTM) -- -0.71 13.63
Return on Investment - 5 Yr. Avg. -- 2.18 15.76
Return on Equity (TTM) -- -3.37 15.39
Return on Equity - 5 Yr. Avg. -- -1.91 17.03
Note: Units in Millions of US Dollars

Performance for BioLine RX Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 38.96%
# of Holders: 34
Total Shares Held: 41,399,879
3 Mo. Net Change: 414,555
# New Positions: 4
# Closed Positions: 5
# Increased Positions: 12
# Reduced Positions: 10
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.